Ontology highlight
ABSTRACT: Background
Sero-surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can reveal trends and differences in subgroups and capture undetected or unreported infections that are not included in case-based surveillance systems.Methods
Cross-sectional, convenience samples of remnant sera from clinical laboratories from 51 U.S. jurisdictions were assayed for infection-induced SARS-CoV-2 antibodies biweekly from October 25, 2020, to July 11, 2021, and monthly from September 6, 2021, to February 26, 2022. Test results were analyzed for trends in infection-induced, nucleocapsid-protein seroprevalence using mixed effects models that adjusted for demographic variables and assay type.Findings
Analyses of 1,469,792 serum specimens revealed U.S. infection-in
SUBMITTER: Wiegand RE
PROVIDER: S-EPMC9716971 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature